INTERPHEX and Parenteral Drug Association Announce Agreement
News Aug 22, 2013
International Pharmaceutical Expo (INTERPHEX) and the Parenteral Drug Association (PDA) have announced a three-year Sponsorship Agreement.
This Sponsorship aligns the objectives of both organizations to service key needs of the global pharmaceutical and biopharmaceutical industry by driving innovation and advancement.
INTERPHEX serves as a strong platform for decision-makers in the pharmaceutical and biopharmaceutical manufacturing community, bringing together over 12,000 industry professionals to learn, network and source from the latest technology, equipment, education and services.
PDA is the premier global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical industry.
Its mission is to develop scientifically sound, practical technical information and resources to advance science and regulation for the pharmaceutical and biopharmaceutical industry through the expertise of its more than 9,500 global members.
“Our Sponsorship of INTERPHEX reflects our support of the continued enhancement of industry learning and improvement, areas we find present at INTERPHEX,” stated Richard Johnson, President and CEO of PDA.
Johnson continued, “Non-profits and corporate entities can work together to leverage best practices, in real-time, to the benefit of our industry. Our collaboration with INTERPHEX is one example of this effort and we are pleased to move forward in this shared endeavor.”
PDA will be directly involved in developing the INTERPHEX conference programming identifying speakers from industry and regulatory agencies and developing a PDA sponsored cGMP Track.
PDA members will have extensive educational and networking opportunities including an exclusive Association Membership Lounge.
“A long-term Sponsorship with PDA, both on national and global levels, aligns us with thought leaders across the globe,” stated Bob Stewart, Vice President of INTERPHEX. “By fostering alliances with successful non-profit organizations like PDA, we acknowledge our investment in the future of the biopharmaceutical industry, and ultimately deliver unrivaled opportunities for knowledge, interaction, and professional growth.”
INTERPHEX will be held March 18-20, 2014 at the Jacobs Javits Center in New York City, NY.
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE